Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Fibrin Structure Marker in Cancer Patients Treated and Not Treated With LMWH

NCT02552381 is registered in ClinicalTrials.gov with Diagnostica Stago R&D as lead sponsor.

NCT NCT02552381
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02552381 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Fibrin Structure Marker in Cancer Patients Treated and Not Treated With LMWH
Lead sponsor
Diagnostica Stago R&D
Phase
Observational
Overall status
Completed
Start date
August 31, 2015
Completion date
December 20, 2019
Enrollment
389 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant tumor